| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1041395533 |
| P356 | DOI | 10.1007/S12265-014-9576-2 |
| P698 | PubMed publication ID | 25119854 |
| P2093 | author name string | Jian-Ping Liu | |
| Jian Feng | |||
| De Li | |||
| Li Miao | |||
| Tao Jing | |||
| Hai-Dong Wang | |||
| Guo-Xiang He | |||
| P2860 | cites work | Tight control of gene expression in mammalian cells by tetracycline-responsive promoters | Q24564850 |
| Transcriptional activation by tetracyclines in mammalian cells | Q28303934 | ||
| Nitric oxide mediates benefits of angiotensin II type 2 receptor overexpression during post-infarct remodeling | Q30312247 | ||
| ANG II type 2 receptor regulates smooth muscle growth and force generation in late fetal mouse development | Q30434317 | ||
| Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial | Q34332467 | ||
| Genetically modified mesenchymal stem cells for improved islet transplantation | Q35256103 | ||
| Role of angiotensin AT1 and AT2 receptors in cardiac hypertrophy and cardiac remodelling | Q35608848 | ||
| ACE inhibitors and angiotensin II receptor antagonists. | Q36441281 | ||
| Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury | Q36748599 | ||
| The angiotensin II type 2 receptor in cardiovascular disease | Q37622575 | ||
| The renin-angiotensin system, bone marrow and progenitor cells | Q38006725 | ||
| A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells | Q38313873 | ||
| Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation | Q39420499 | ||
| Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised cl | Q40525372 | ||
| Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances | Q40846822 | ||
| Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivo | Q44223354 | ||
| Upregulation of Angiotensin II Type 2 Receptor and Limitation of Myocardial Stunning by Angiotensin II Type 1 Receptor Blockers during Reperfused Myocardial Infarction in the Rat | Q44594372 | ||
| Expression of endothelial angiotensin II receptor mRNA in pregnancy-induced hypertension | Q44672622 | ||
| Inhibitory effect of epigallocatechin 3-O-gallate on vascular smooth muscle cell hypertrophy induced by angiotensin II. | Q44723447 | ||
| Chimeric DNA-RNA hammerhead ribozyme targeting transforming growth factor-beta 1 mRNA inhibits neointima formation in rat carotid artery after balloon injury | Q44732256 | ||
| Gene therapy for chronic myocardial ischemia using platelet-derived endothelial cell growth factor in dogs | Q45063910 | ||
| Chronic ventricular myocyte-specific overexpression of angiotensin II type 2 receptor results in intrinsic myocyte contractile dysfunction | Q45063927 | ||
| Inhibition of neointimal hyperplasia after balloon injury by cis-element 'decoy' of early growth response gene-1 in hypercholesterolemic rabbits | Q45871472 | ||
| Leptin enhances the recruitment of endothelial progenitor cells into neointimal lesions after vascular injury by promoting integrin-mediated adhesion. | Q46460417 | ||
| Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries | Q46618559 | ||
| Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-kappaB and activator protein 1 in a redox-sensitive manner | Q46653062 | ||
| Endothelin-1 expression in vascular adventitial fibroblasts | Q46661247 | ||
| Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution | Q46802781 | ||
| Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development | Q46885968 | ||
| Ventricular-specific expression of angiotensin II type 2 receptors causes dilated cardiomyopathy and heart failure in transgenic mice | Q47752119 | ||
| Overexpression of angiotensin II type 2 receptor suppresses neointimal hyperplasia in a rat carotid arterial balloon injury model. | Q50523564 | ||
| Angiotensin II receptor blocker inhibits neointimal hyperplasia through regulation of smooth muscle-like progenitor cells. | Q50668553 | ||
| Bone marrow cells contribute to neointimal formation after stent implantation in swine. | Q51080522 | ||
| Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo. Berberine improves neointima formation in a rat model. | Q53616543 | ||
| Angiotensin II receptor expression following intestinal transplantation in mice. | Q54612047 | ||
| Osteopontin plays an important role in the development of medial thickening and neointimal formation | Q74452974 | ||
| Smooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells | Q78304752 | ||
| Tumor necrosis factor receptor-2 signaling attenuates vein graft neointima formation by promoting endothelial recovery | Q79843748 | ||
| Temporal and spatial characterization of cellular constituents during neointimal hyperplasia after vascular injury: Potential contribution of bone-marrow-derived progenitors to arterial remodeling | Q81039995 | ||
| alpha8beta1 Integrin expression in the rat carotid artery: involvement in smooth muscle cell migration and neointima formation | Q81421607 | ||
| Dermatan sulfate and bone marrow mononuclear cells used as a new therapeutic strategy after arterial injury in mice | Q83245866 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| P304 | page(s) | 635-643 | |
| P577 | publication date | 2014-08-14 | |
| P1433 | published in | Journal of Cardiovascular Translational Research | Q6294906 |
| P1476 | title | Conditional expression of the type 2 angiotensin II receptor in mesenchymal stem cells inhibits neointimal formation after arterial injury | |
| P478 | volume | 7 |
| Q41959178 | Endothelial‑like cells differentiated from mesenchymal stem cells attenuate neointimal hyperplasia after vascular injury | cites work | P2860 |
Search more.